NCT05926622 Clinical and Radiological Outcomes of Medacta Shoulder System FR
| NCT ID | NCT05926622 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Medacta International SA |
| Condition | Primary Osteoarthritis |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2022-03-15 |
| Primary Completion | 2032-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2022-03-15 with a primary completion date of 2032-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a post-marketing surveillance on Medacta Shoulder System
Eligibility Criteria
Inclusion Criteria: * Patients older than 18 years * Patient with one of the following diagnosis: Primary osteoarthritis Secondary osteoarthritis Cuff tear arthropathy; insufficient rotator cuff Acute fracture (\<21d) Rheumatoid or inflammatory arthritis Avascular necrosis Other posttraumatic condition Revision of shoulder arthroplasty Exclusion Criteria: * Patients with malignant diseases (at the time of surgery) * Patients with proven or suspect infections (at the time of surgery) * Patients with functional deficits other than dysfunction of the shoulder (at the time of surgery) * Patients with known incompatibility or allergy to products materials (at the time of surgery)
Contact & Investigator
Bruno Toussaint
PRINCIPAL INVESTIGATOR
Clinique Générale Annecy
Frequently Asked Questions
Who can join the NCT05926622 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Primary Osteoarthritis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05926622 currently recruiting?
Yes, NCT05926622 is actively recruiting participants. Contact the research team at girardi@medacta.ch for enrollment information.
Where is the NCT05926622 trial being conducted?
This trial is being conducted at Annecy, France.
Who is sponsoring the NCT05926622 clinical trial?
NCT05926622 is sponsored by Medacta International SA. The principal investigator is Bruno Toussaint at Clinique Générale Annecy. The trial plans to enroll 200 participants.